Improving the health and quality of life of patients is the goal of the research-driven pharmaceutical company Boehringer Ingelheim. The focus in doing so is on diseases for which no satisfactory treatment option exists to date. The company therefore concentrates on developing innovative therapies that can extend patients’ lives. In animal health, Boehringer Ingelheim stands for advanced prevention.
As a family-owned company, Boehringer Ingelheim plans in generations and focuses on long-term success. The company therefore aims at organic growth from its own resources with simultaneous
openness to partnerships and strategic alliances in research. In everything it does, Boehringer Ingelheim naturally adopts responsibility towards mankind and the environment.
Our corporate culture is rooted in our sense of responsibility. We strive to be caring, considerate and open in everything we do. We are involved in social development projects worldwide, e.g. our “Making More Health” initiative; and we promote a healthy work-life balance for all our employees. In addition, the fact we reinvest more than 20% of our revenues into R&D to develop our medications organically sets us apart from other pharmaceutical companies.